Excess risk of chronic physical conditions associated with depression and anxiety

Rituparna Bhattacharya, Chan Shen, Usha Sambamoorthi, Rituparna Bhattacharya, Chan Shen, Usha Sambamoorthi

Abstract

Background: Depression and anxiety have been reported to be associated with chronic physical conditions. We examined the excess risk of chronic physical conditions associated with depression and/or anxiety within a multivariate framework controlling for demographic and modifiable lifestyle risk factors.

Methods: We used a retrospective cross-sectional study design. Study participants were adults aged 22-64 years from 2007 and 2009 Medical Expenditure Panel Survey. We defined presence of depression-anxiety based on self-reported depression and anxiety and classified adults into 4 groups: 1) depression only; 2) anxiety only; 3) comorbid depression and anxiety 4) no depression and no anxiety. We included presence/absence of arthritis, asthma, chronic obstructive pulmonary disorder, diabetes, heart disease, hypertension, and osteoporosis as dependent variables. Complementary log-log regressions were used to examine the excess risk associated with depression and/or anxiety for chronic physical conditions using a multivariate framework that controlled for demographic (gender, age, race/ethnicity) and modifiable lifestyle (obesity, lack of physical activity, smoking) risk factors. Bonferroni correction for multiple comparisons was applied and p ≤0.007 was considered statistically significant.

Results: Overall, 7% had only depression, 5.2% had only anxiety and 2.5% had comorbid depression and anxiety. Results from multivariable regressions indicated that compared to individuals with no depression and no anxiety, individuals with comorbid depression and anxiety, with depression only and with anxiety only, all had higher risk of all the chronic physical conditions. ARRs for comorbid depression and anxiety ranged from 2.47 (95% CI: 1.47, 4.15; P = 0.0007) for osteoporosis to 1.64 (95% CI: 1.33, 2.04; P < 0.0001) for diabetes. Presence of depression only was also found to be significantly associated with all chronic conditions except for osteoporosis. Individuals with anxiety only were found to have a higher risk for arthritis, COPD, heart disease and hypertension.

Conclusion: Presence of depression and/or anxiety conferred an independent risk for having chronic physical conditions after adjusting for demographic and modifiable lifestyle risk factors.

References

    1. Steptoe A. Depression and physical illness. Cambridge, UK: Cambridge University Press; 2007.
    1. Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci. 2011;13(1):7–23.
    1. Rotella F, Mannucci E. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry. 2013;74(1):31–37. doi: 10.4088/JCP.12r07922.
    1. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med. 2003;65(2):201–210. doi: 10.1097/01.PSY.0000058371.50240.E3.
    1. Patten SB, Williams JV, Lavorato DH, Campbell NR, Eliasziw M, Campbell TS. Major depression as a risk factor for high blood pressure: epidemiologic evidence from a national longitudinal study. Psychosom Med. 2009;71(3):273–279. doi: 10.1097/PSY.0b013e3181988e5f.
    1. Tolea MI, Black SA, Carter-Pokras OD, Kling MA. Depressive symptoms as a risk factor for osteoporosis and fractures in older Mexican American women. Osteoporos Int. 2007;18(3):315–322. doi: 10.1007/s00198-006-0242-7.
    1. Mussolino ME. Depression and hip fracture risk: the NHANES I epidemiologic follow-up study. Public Health Rep. 2005;120(1):71–75.
    1. Whooley MA, Kip KE, Cauley JA, Ensrud KE, Nevitt MC, Browner WS. Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1999;159(5):484–490. doi: 10.1001/archinte.159.5.484.
    1. Cizza G, Primma S, Coyle M, Gourgiotis L, Csako G. Depression and Osteoporosis: A Research Synthesis with Meta-Analysis. Horm Metab Res. 2010;42(7):467–482. doi: 10.1055/s-0030-1252020.
    1. Druss BG, Rask K, Katon WJ. Major depression, depression treatment and quality of primary medical care. Gen Hosp Psychiatry. 2008;30(1):20–25. doi: 10.1016/j.genhosppsych.2007.08.015.
    1. Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med. 2002;23(1):51–61. doi: 10.1016/S0749-3797(02)00439-7.
    1. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan. Diabetes Care. 2008;31(12):2383–2390. doi: 10.2337/dc08-0985.
    1. Covey LS. Tobacco cessation among patients with depression. Prim Care. 1999;26(3):691–706. doi: 10.1016/S0095-4543(05)70124-X.
    1. Covey LS, Glassman AH, Stetner F. Major depression following smoking cessation. Am J Psychiatry. 1997;154(2):263–265.
    1. Covey LS, Glassman AH, Stetner F. Cigarette smoking and major depression. J Addict Dis. 1998;17(1):35–46. doi: 10.1300/J069v17n01_04.
    1. Rutledge T, Hogan BE. A quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom Med. 2002;64(5):758–766. doi: 10.1097/01.PSY.0000031578.42041.1C.
    1. Johannessen L, Strudsholm U, Foldager L, Munk-Jørgensen P. Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia. J Affect Disord. 2006;95(1):13–17.
    1. Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res. 2007;62(1):31–38. doi: 10.1016/j.jpsychores.2006.07.009.
    1. Edwards LE, Mezuk B. Anxiety and risk of type 2 diabetes: evidence from the Baltimore Epidemiologic Catchment Area Study. J Psychosom Res. 2012;73(6):418–423. doi: 10.1016/j.jpsychores.2012.09.018.
    1. Dorn LD, Susman EJ, Pabst S, Huang B, Kalkwarf H, Grimes S. Association of depressive symptoms and anxiety with bone mass and density in ever-smoking and never-smoking adolescent girls. Arch Pediatr Adolesc Med. 2008;162(12):1181–1188. doi: 10.1001/archpedi.162.12.1181.
    1. Jacobs J, Andersson G, Bell J, Weinstein S, Dormans J, Gnatz S, Lane N, Puzas J, St Clair E, Yelin E. Burden of musculoskeletal diseases in the United States: Prevalence, societal, and economic cost. Rosemont: American Academy of Orthopaedic Surgeons; 2008.
    1. Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. Chest. 2013;144:766–777. doi: 10.1378/chest.12-1911.
    1. Scott KM, Oakley Browne MA, McGee MA, Wells JE. Mental-physical comorbidity in Te Rau Hinengaro: the New Zealand Mental Health Survey. Aust N Z J Psychiatry. 2006;40(10):882–888.
    1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA. 2003;289(23):3095–3105. doi: 10.1001/jama.289.23.3095.
    1. Lamers F, van Oppen P, Comijs HC, Smit JH, Spinhoven P, van Balkom AJ, Nolen WA, Zitman FG, Beekman AT, Penninx BW. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA) J Clin Psychiatry. 2011;72(3):341–348. doi: 10.4088/JCP.10m06176blu.
    1. Scott KM, Bruffaerts R, Tsang A, Ormel J, Alonso J, Angermeyer MC, Benjet C, Bromet E, de Girolamo G, de Graaf R. et al.Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys. J Affect Disord. 2007;103(1–3):113–120.
    1. Stunkard AJ, Faith MS, Allison KC. Depression and obesity. Biol Psychiatry. 2003;54(3):330–337. doi: 10.1016/S0006-3223(03)00608-5.
    1. McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, Nemeroff CB. Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry. 2004;65(5):634–651. doi: 10.4088/JCP.v65n0507. quiz 730.
    1. van Gool CH, Kempen GI, Penninx BW, Deeg DJ, Beekman AT, van Eijk JT. Relationship between changes in depressive symptoms and unhealthy lifestyles in late middle aged and older persons: results from the Longitudinal Aging Study Amsterdam. Age Ageing. 2003;32(1):81–87. doi: 10.1093/ageing/32.1.81.
    1. Patton GC, Carlin JB, Coffey C, Wolfe R, Hibbert M, Bowes G. Depression, anxiety, and smoking initiation: a prospective study over 3 years. Am J Public Health. 1998;88(10):1518–1522. doi: 10.2105/AJPH.88.10.1518.
    1. Ströhle A. Physical activity, exercise, depression and anxiety disorders. J Neural Transm. 2009;116(6):777–784. doi: 10.1007/s00702-008-0092-x.
    1. American Diabetic Association. The Cardiometabolic Risk Initiative. URL: .
    1. National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. Arthritis-Risk Factors. URL: .
    1. World Health Organization- Global Alliance against Chronic Respiratory Diseases. Risk Factors for Chronic Respiratory Diseases. URL: .
    1. Medical Expenditure Panel Survey Data Documentation. MEPS HC-129: 2007 Full Year Consolidated Data File. URL: .
    1. Medical Expenditure Panel Survey Clinical Classification Code to ICD-9-CM Code Crosswalk. URL: .
    1. Medical Expenditure Panel Survey Data Documentation. MEPS HC-113: 2007 Full Year Consolidated Data File. URL: .
    1. National Heart, Lung and Blood Institute Overview and Planning Documents . 2012 Fact Book. Disease Statisics. URL: .
    1. About BMI for Adults. URL: .
    1. Altman DG, Deeks JJ, Sackett DL. Odds ratios should be avoided when events are common. BMJ. 1998;317(7168):1318.
    1. Penman AD, Johnson WD. Complementary log-log regression for the estimation of covariate-adjusted prevalence ratios in the analysis of data from cross-sectional studies. Biometrical J Biometrische Zeitschrift. 2009;51(3):433–442. doi: 10.1002/bimj.200800236.
    1. Cummings P. The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med. 2009;163(5):438. doi: 10.1001/archpediatrics.2009.31.
    1. SAS Institute, Cary, NC; RTI, Research Triangle Park, NC. In. North Carolina US: SAS Institute;
    1. Broadley A, Korszun A, Jones C, Frenneaux M. Arterial endothelial function is impaired in treated depression. Heart. 2002;88(5):521–523. doi: 10.1136/heart.88.5.521.
    1. Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med. 2000;108(1):2–8. doi: 10.1016/S0002-9343(99)00301-0.
    1. Bhattacharjee S, Bhattacharya R, Kelley GA, Sambamoorthi U. Antidepressant use and new‒onset diabetes: a systematic review and meta‒analysis. Diabetes Metab Res Rev. 2013;29(4):273–284. doi: 10.1002/dmrr.2393.
    1. Cohen D. Atypical antipsychotics and new onset diabetes mellitus: an overview of the literature. Pharmacopsychiatry. 2004;37:1–11.
    1. Hasnain M, Hollett B. Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians. Postgrad Med. 2012;124(4):154. doi: 10.3810/pgm.2012.07.2577.
    1. Madhusoodanan S, Parida S, Jimenez C. Hyperprolactinemia associated with psychotropics—a review. Hum Psychopharm clin. 2010;25(4):281–297. doi: 10.1002/hup.1116.
    1. Vartej P, Poiana C, Vartej I. Effects of hyperprolactinemia on osteoporotic fracture in premenopausal women. Gynecol Endocrinol. 2001;15(1):43–47.
    1. Player MS, Peterson LE. Anxiety disorders, hypertension, and cardiovascular risk: a review. Int J Psychiatry Med. 2011;41(4):365–377. doi: 10.2190/PM.41.4.f.
    1. Jain A, Lolak S. Psychiatric aspects of chronic lung disease. Curr Psychiatry Rep. 2009;11(3):219–225. doi: 10.1007/s11920-009-0034-9.
    1. Bruce TO. Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications. Curr Psychiatry Rep. 2008;10(3):258–264. doi: 10.1007/s11920-008-0042-1.
    1. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan K, Nemeroff CB, Bremner JD, Carney RM, Coyne JC. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005;58(3):175–189. doi: 10.1016/j.biopsych.2005.05.001.
    1. Robson D, Gray R. Serious mental illness and physical health problems: a discussion paper. Int J Nurs Stud. 2007;44(3):457–466. doi: 10.1016/j.ijnurstu.2006.07.013.
    1. Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J. 2000;140(4):77–83. doi: 10.1067/mhj.2000.109981.
    1. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99(16):2192–2217. doi: 10.1161/01.CIR.99.16.2192.
    1. Pollock BG, Laghrissi-Thode F, Wagner WR. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol. 2000;20(2):137. doi: 10.1097/00004714-200004000-00004.
    1. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol. 2002;90(12):1279–1283. doi: 10.1016/S0002-9149(02)02863-1.
    1. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry. 2003;54:317–329. doi: 10.1016/S0006-3223(03)00569-9.
    1. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004;58(1):65–70. doi: 10.1080/08039480310000824.
    1. Bremmer MA, Beekman AT, Deeg DJ, Penninx BW, Dik MG, Hack CE, Hoogendijk WJ. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord. 2008;106(3):249–255. doi: 10.1016/j.jad.2007.07.002.
    1. Cameron OG, Abelson JL, Young EA. Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic function. Biol Psychiatry. 2004;56(11):875–883. doi: 10.1016/j.biopsych.2004.08.007.
    1. Ehlert U, Gaab J, Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol Psychol. 2001;57(1–3):141–152.
    1. Joynt KE, Whellan DJ, O’Connor CM. Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J Card Fail. 2004;10(3):258–271. doi: 10.1016/j.cardfail.2003.09.008.
    1. Varghese FP, Brown ES. The Hypothalamic-Pituitary-Adrenal Axis in Major Depressive Disorder: A Brief Primer for Primary Care Physicians. Prim Care Companion J Clin Psychiatry. 2001;3(4):151–155. doi: 10.4088/PCC.v03n0401.
    1. Van Lieshout RJ, Bienenstock J, MacQueen GM. A review of candidate pathways underlying the association between asthma and major depressive disorder. Psychosom Med. 2009;71(2):187–195. doi: 10.1097/PSY.0b013e3181907012.
    1. Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Kanayama Y, Furukawa TA, Tokudome S. Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Care Res. 2009;61(8):1018–1024. doi: 10.1002/art.24647.
    1. Roy-Byrne PP, Wagner A. Primary care perspectives on generalized anxiety disorder. J Clin Psychiatry. 2004;65:20.
    1. Harris M. The role of primary health care in preventing the onset of chronic disease, with a particular focus on the lifestyle risk factors of obesity, tobacco and alcohol. National Preventative Health Taskforce: Canberra; 2008.
    1. Rittenhouse DR, Shortell SM. The patient-centered medical home. JAMA. 2009;301(19):2038–2040. doi: 10.1001/jama.2009.691.
    1. Druss BG, Bornemann TH. Improving health and health care for persons with serious mental illness: the window for US federal policy change. JAMA. 2010;303(19):1972–1973. doi: 10.1001/jama.2010.615.
    1. Butler M, Kane RL, McAlpine D, Kathol RG, Fu SS, Hagedorn H, Wilt TJ. Integration of mental health/substance abuse and primary care No. 173 (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-02-0009.) AHRQ Publication No. 09-E003. Rockville, MD: Agency for Healthcare Research and Quality; 2008.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera